Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (47)Saphnelo self-administration approved in the US
Preheader (136)Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
Typography
Arial
Colors
Text Analysis
Body Words127
Subject Words6
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px716 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekTuesday
TimeEvening

Saphnelo self-administration approved in the US

Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
Saphnelo self-administration approved in the US